Zydus Cadila and Eczacibasi enter into a strategic collaboration to market biosimilars in Turkey

June 28, 2016 10:53 AM


Zydus Cadila and Eczacibasi Ilaç Pazarlama A.S., a healthcare company of Turkey have signed a strategic collaboration agreement to market biotech products in the Turkish market.

The agreement involves the import of biosimilars which are currently unavailable in the country especially for the treatment of cancer and also paves the way for a long term strategic collaboration to produce and launch new products in the market.

The agreement was signed at the headquarters of Eczacibasi Holding located in Istanbul by Mr. Pankaj Patel, Chairman and Managing Director of Zydus Group, Dr. Sharvil Patel, Deputy Managing Director of Zydus Group and Mr. Bülent Eczacibasi, Chairman of Eczacibasi Holding, Dr. Erdal Karamercan, CEO of Eczacibasi Group, and Ms. Elif Çelik, Eczacibasi Healthcare Group President.

Speaking on the agreement, Mr. Pankaj Patel stated, “We are glad to partner with Eczacibasi, a leading group in the field of healthcare in Turkey, to make available biotech therapies for patients in Turkey. The long term agreement between both partners to enrich this collaboration through introduction of new products, will augur well for healthcare access beyond geographies.”

In his speech at the ceremony, Mr. Bülent Eczacibasi stated that as Eczacibasi Group, they believe that new collaborations enabling innovation and creating added value in the field of healthcare are very important and also said “Our target is to ensure that the important worldwide advances in the field of biotech products are simultaneously reflected and reach more people in our country, and think that Zydus is a very right partner in this regard”.

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)

Latest News on Biosimilar News

Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?


Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!